What’s Oncology’s Best Asset?


The revenue is in the drug. Yet the value is in the team.
In most specialties, physician services drive the revenue. Then there’s oncology. Pharmaceuticals do the earning: the majority of oncology practice revenue comes from drug treatments, a figure that has historically climbed as high as 77%.
Private equity has taken note. Between 2003 and 2022, private equity-backed firms acquired 724 oncology clinics, about 10% of all U.S. oncology clinic locations, according to a study in JAMA Internal Medicine. In seven states, they own more than 20% of cancer clinics. Hospitals, meanwhile, are earnestly working to keep cancer care in-house, as a pillar of their operating strategy.
Yet despite all the money in the drugs, oncology may be medicine’s ultimate team sport. “In a field where drugs drive the revenue, it’s easy to treat the team as overhead—and that gets it backward,” says Li Ern Chen, MD, MS, market leader in the Physician Workforce Solutions practice at Korn Ferry. For-profit or nonprofit, patients and clinicians choose a cancer center for its people.
The Team Is the Asset
In oncology, the team is the program, and its shape changes by disease. A breast cancer program needs plastic surgeons and genetic counselors, while a lung cancer program leans on interventional pulmonologists and a smoking-cessation team. “It’s not all about oncologists and radiologists,” says Dan Stech, senior client partner in the Healthcare Consulting practice at Korn Ferry. “Their hiring goes deep, from psychological staff all the way to tattoo artists.”
The programs themselves also grow differently: breast and GI programs expand through mammography and colonoscopy volume, while programs for cancers with no routine screening grow by referral. “You can’t just treat oncology as a catch-all,” says Opal Greenway, senior client partner in the Health Advisory practice at Korn Ferry. “You have to understand how the program grows before you can determine the team it needs.” That team shape should drive recruiting. Hiring five people for a cancer program is not five separate searches, but assembling five people who will organize around patient needs and work well together.
A high-functioning team also saves lives: a 2023 meta-analysis in the Annals of Medicine and Surgery found that breast cancer patients overseen by well-organized multidisciplinary teams had a roughly 20% lower death risk, and a 2025 review in Cancer Treatment Reviews across cancer types found the reduction in death risk ranged from 4% to 20%.
A team that works pays off financially in three ways: it attracts patients by delivering a better experience, it keeps its staff, and it cuts delays in treatment. Keeping people is easier when the work means something, and in oncology it does. “The commitment to mission is unlike what you see in most executive searches,” says Lauren Glaccum, senior leader in the Health Systems and Academic practice at Korn Ferry. “It’s palpable.”
The alternative is unforgiving. When a care team never quite gels, the organization pays in burnout, delays, and empty infusion chairs. Cancer is increasingly a chronic disease, managed over years through repeated rounds of treatment and surveillance, and patients can switch where they get that care whenever the experience falls short. Staff can leave too: losing a single physician costs the organization $750K to $1.8M, according to 2024 figures from healthcare tech firm Premier losing a single bedside nurse costs a hospital an average of $60,090, according to the 2026 NSI National Health Care Retention & RN Staffing Report.
In a field where drugs drive revenue, the team is the primary asset. It deserves to be recruited, built, and managed like one.

Healthcare
Enabling people and organizations to exceed potential & transform tomorrow's healthcare ecosystem.
How We Can Help
Want to learn more about Korn Ferry's Physician Workforce Solutions practice? Subscribe to our Physician Workforce Insights newsletter.
